[
    "{\"step_by_step_thinking\": \"Document 0 states that Ozanimod has been approved for UC therapy and has shown to be significantly more effective than placebo in inducing clinical remission in moderate to severe UC patients. Document 1 also mentions that the FDA approved Ozanimod for the treatment of moderately to severely active ulcerative colitis. Document 3 further supports this by stating that Ozanimod has shown long-term safety and efficacy in patients with moderately to severely active ulcerative colitis. Document 4, 5, 7, 8, 9, 10, 13, 15, 19, 23, 24, 25, 26, 28, 29, and 31 all provide evidence supporting the effectiveness of Ozanimod in treating ulcerative colitis.\", \"answer_choice\": \"A\"}"
]